Save information for later
Sign Up

Learn About Generalized Pustular Psoriasis (GPP)

What is the definition of Generalized Pustular Psoriasis (GPP)?

Generalized pustular psoriasis (GPP) is a severe form of a skin disorder called psoriasis. GPP and other forms of psoriasis are caused by abnormal inflammation. Inflammation is a normal immune system response to injury and foreign invaders (such as bacteria). However, when inflammation is abnormal and uncontrolled, it can damage the body's tissues and organs. Individuals with GPP have repeated episodes in which large areas of skin become red and inflamed and develop small pus-filled blisters (pustules). The skin problems can be accompanied by fever, extreme tiredness (fatigue), muscle weakness, an increased number of white blood cells, and other signs of inflammation throughout the body (systemic inflammation). The inflammation problems subside and reappear often. Episodes can be triggered by infection, exposure to or withdrawal from certain medications, menstruation, or pregnancy, although the trigger is often unknown. GPP can be life-threatening if not treated.

What are the causes of Generalized Pustular Psoriasis (GPP)?

Mutations in several genes, including IL36RN and CARD14, increase the risk of developing GPP. These two genes provide instructions for making proteins that play roles in regulating inflammation, particularly in the skin. The IL-36Ra protein, produced from the IL36RN gene, blocks the activity of specific proteins that trigger signaling pathways to promote skin inflammation. IL36RN gene mutations involved in GPP reduce the amount of IL-36Ra protein in the skin. Without control by IL-36Ra, signaling pathways that promote inflammation are overly active.

How prevalent is Generalized Pustular Psoriasis (GPP)?

GPP is the rarest form of psoriasis. Although the worldwide prevalence of GPP is unknown, the condition is estimated to affect 2 per million people in Europe. It also occurs in approximately 0.6 per million people each year in Japan.

Is Generalized Pustular Psoriasis (GPP) an inherited disorder?

When associated with IL36RN gene mutations, risk of GPP is typically inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene.

Who are the top Generalized Pustular Psoriasis (GPP) Local Doctors?
Bruce E. Strober
Elite in Generalized Pustular Psoriasis (GPP)
Elite in Generalized Pustular Psoriasis (GPP)

Central Connecticut Dermatology PLLC

1 Willowbrook Rd, Suite 2, 
Cromwell, CT 
Languages Spoken:
English

Bruce Strober is a Dermatologist in Cromwell, Connecticut. Dr. Strober is rated as an Elite provider by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). His top areas of expertise are Psoriasis, Plaque Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

Diamant Thaci
Elite in Generalized Pustular Psoriasis (GPP)
Elite in Generalized Pustular Psoriasis (GPP)
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Diamant Thaci practices in Luebeck, Germany. Thaci is rated as an Elite expert by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). Their top areas of expertise are Psoriasis, Plaque Psoriasis, Atopic Dermatitis, and Psoriatic Arthritis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Generalized Pustular Psoriasis (GPP)
Elite in Generalized Pustular Psoriasis (GPP)
Nagoya, JP 

Akimichi Morita practices in Nagoya, Japan. Morita is rated as an Elite expert by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). Their top areas of expertise are Generalized Pustular Psoriasis (GPP), Pustular Psoriasis, Pustules, Psoriasis, and Carotid Artery Surgery.

What are the latest Generalized Pustular Psoriasis (GPP) Clinical Trials?
A Phase II, Multicenter, Double-blind, Randomized, Placebo Parallel-controlled Trial to Evaluate the Efficacy and Safety of HB0034 in Patients with GPP Presenting with an Acute Flare of Moderate to Severe Intensity

Summary: This is a phase II, multicenter, double-blind, randomized, placebo parallel-controlled clinical trial to evaluate the efficacy and safety of HB0034 in patients with generalized pustular psoriasis (GPP) presenting with an acute flare of moderate to severe intensity.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase IIb, Long-Term Extension Study to Evaluate the Safety and Efficacy of HB0034 in the Treatment of Adult Subjects With Generalized Pustular Psoriasis

Summary: This is a Phase IIb, long term extension study to evaluate the safety and efficacy of HB0034 in adult subjects with generalized pustular psoriasis (GPP).

Who are the sources who wrote this article ?

Published Date: May 01, 2017
Published By: National Institutes of Health